<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="3-part\PMC7040968\results\search\disease\results.xml">
  <result pre="adherent MDCK cells, and LLC�?MK2 cells for selective isolation of" exact="influenza" post="viruses to be used as vaccine seeds HARADA et"/>
  <result pre="the original work is properly cited.file:IRV-14-204.pdf Abstract Abstract Background Cell�?based" exact="influenza" post="vaccines can solve the problem of the frequent occurrence"/>
  <result pre="culture; however, clinical samples risk harboring respiratory viruses other than" exact="influenza" post="virus. Therefore, it is necessary to investigate the patterns"/>
  <result pre="samples and explore whether cell culture technology can selectively propagate" exact="influenza" post="viruses from samples containing other respiratory viruses. Methods A"/>
  <result pre="total of 341 clinical specimens were collected from patients with" exact="influenza" post="or influenza�?like illness and analyzed by ResPlex II assay"/>
  <result pre="assay again to investigate whether each cell line could amplify" exact="influenza" post="viruses and eliminate other respiratory viruses. Results Double infections"/>
  <result pre="double and triple infection, MDCK�?S and MDCK�?A could selectively propagate" exact="influenza" post="viruses, while eliminating all contaminating viruses. In contrast, LLC�?MK2D"/>
  <result pre="contaminating viruses. In contrast, LLC�?MK2D showed lower isolation efficiency for" exact="influenza" post="virus and higher isolation efficiency for coxsackievirus/echovirus than MDCK�?S"/>
  <result pre="MDCK�?S and MDCK�?A are considered suitable for the preparation of" exact="influenza" post="vaccine seed viruses without adventitious agents or egg�?adaptation mutations."/>
  <result pre="without adventitious agents or egg�?adaptation mutations. adventitious virus cell�?based vaccine" exact="influenza" post="Madin�?Darby canine kidney cell line vaccine seed virus Funding"/>
  <result pre="adherent MDCK cells, and LLC�?MK2 cells for selective isolation of" exact="influenza" post="viruses to be used as vaccine seeds. Influenza Other"/>
  <result pre="severe illness, including high fever, headache, myalgia, and pneumonia. Annual" exact="influenza" post="epidemics worldwide cause approximately three to five million cases"/>
  <result pre="resulting in a great social impact.1 The economic burden of" exact="influenza" post="has been estimated to be $47.2�?$149.5 billion per year"/>
  <result pre="Influenza vaccine, one of the most effective measures to prevent" exact="influenza" post="virus infection, is mainly produced in embryonated chicken eggs."/>
  <result pre="virus infection, is mainly produced in embryonated chicken eggs. However," exact="influenza" post="viruses propagated in eggs frequently acquire antigenic alteration through"/>
  <result pre="samples have a risk of harboring respiratory viruses other than" exact="influenza" post="viruses. Moreover, mammalian cells might amplify contaminating human viruses"/>
  <result pre="samples and explore whether cell culture technology can selectively propagate" exact="influenza" post="viruses from samples containing other respiratory viruses. For the"/>
  <result pre="from samples containing other respiratory viruses. For the propagation of" exact="influenza" post="viruses, cell lines such as Madin�?Darby canine kidney (MDCK)"/>
  <result pre="1958 and has a long history in the studies of" exact="influenza" post="viruses. The conventional MDCK cell with adherent growth (MDCK�?A)"/>
  <result pre="vaccine seed viruses, since it supports efficient growth of human" exact="influenza" post="viruses.10, 11 The MDCK33016PF suspension cell line, designated as"/>
  <result pre="this paper, was first developed and utilized to produce seasonal" exact="influenza" post="vaccines.11, 12, 13 Suspension cells are superior to adherent"/>
  <result pre="virus yield. Therefore, MDCK�?S could be a suitable substrate for" exact="influenza" post="vaccine seed preparation. LLC�?MK2, established from the kidney of"/>
  <result pre="been used to propagate a variety of viruses, including the" exact="influenza" post="virus.14, 15, 16 LLC�?MK2D, which is a sub�?line of"/>
  <result pre="the ability of MDCK�?S, MDCK�?A, and LLC�?MK2D cells to propagate" exact="influenza" post="viruses while eliminating other respiratory viruses. 2 MATERIALS AND"/>
  <result pre="selected 341 clinical specimens from the patients diagnosed as having" exact="influenza" post="or influenza�?like illness based on their clinical symptoms and/or"/>
  <result pre="for influenza. These patients visited the hospitals during the 2006/2007" exact="influenza" post="season (from January 2007 to May 2007), 2007/2008 influenza"/>
  <result pre="2006/2007 influenza season (from January 2007 to May 2007), 2007/2008" exact="influenza" post="season (from December 2007 to April 2008), or 2008/2009"/>
  <result pre="influenza season (from December 2007 to April 2008), or 2008/2009" exact="influenza" post="season (from September 2008 to February 2009) in Japan."/>
  <result pre="were performed again to investigate the presence or absence of" exact="influenza" post="and other respiratory viruses. 2.3 ResPlex II assay Viral"/>
  <result pre="virus type A (RSVA), respiratory syncytial virus type B (RSVB)," exact="influenza" post="A virus (INFA), influenza B virus (INFB), parainfluenza virus"/>
  <result pre="respiratory syncytial virus type B (RSVB), influenza A virus (INFA)," exact="influenza" post="B virus (INFB), parainfluenza virus type 1, parainfluenza virus"/>
  <result pre="RESULTS A total of 341 samples from patients diagnosed with" exact="influenza" post="or influenza�?like illness were analyzed for 18 respiratory viruses"/>
  <result pre="and CVEV�?RHV and CVEV�?RSVB exhibited positive correlation (Table 2). However," exact="influenza" post="viruses were not significantly correlated with most of the"/>
  <result pre="would mutually interfere in each other's infection, whereas infection with" exact="influenza" post="and other viruses would occur independently in most cases."/>
  <result pre="To investigate whether MDCK�?S, MDCK�?A, and LLC�?MK2D can selectively amplify" exact="influenza" post="virus in the presence of other respiratory viruses, co�?infection"/>
  <result pre="in the presence of other respiratory viruses, co�?infection samples containing" exact="influenza" post="virus plus other viruses were inoculated and passaged in"/>
  <result pre="double infection, MDCK�?S and MDCK�?A could selectively allow proliferation of" exact="influenza" post="viruses while eliminating all contaminating viruses (Table 3). Particularly,"/>
  <result pre="all contaminating viruses (Table 3). Particularly, the isolation rates of" exact="influenza" post="viruses were significantly higher than those of co�?existing viruses"/>
  <result pre="infection 3 (INFA and RHV, P &amp;lt; .05). For LLC�?MK2D," exact="influenza" post="viruses were isolated from the groups of double infection"/>
  <result pre="of adventitious viruses; however, the differences in detection rates between" exact="influenza" post="virus and others were not significant. In the double"/>
  <result pre="of CVEV was obtained from four specimens (25%), although no" exact="influenza" post="virus was amplified during cell passages. Table 3 Cell"/>
  <result pre="passages. Table 3 Cell passages of field samples positive for" exact="influenza" post="virus plus other viruses Group Target viruses Clinical samples"/>
  <result pre="0% (0/1) 0% (0/1) 0% (0/1) *The detection rate of" exact="influenza" post="virus was significantly higher than that of the other"/>
  <result pre="other co�?infected viruses (P &amp;lt; .01). **The detection rate of" exact="influenza" post="virus was significantly higher than that of the other"/>
  <result pre="viruses, we passaged clinical specimens containing respiratory viruses other than" exact="influenza" post="virus in the three cell lines. The ResPlex II"/>
  <result pre="passages of field samples positive for respiratory viruses other than" exact="influenza" post="viruses Group Target viruses Clinical samples (positive/total) MDCK�?S�?passaged samples"/>
  <result pre="suitability of three cell lines as a substrate to multiply" exact="influenza" post="viruses selectively. Brunstein et al17 have reported some statistically"/>
  <result pre="attenuation of interferon signaling by virally encoded proteins such as" exact="influenza" post="virus NS1. It is also possible that the required"/>
  <result pre="the present study for detection of more significant associations between" exact="influenza" post="viruses and other viruses. These results suggest that co�?existence"/>
  <result pre="viruses and other viruses. These results suggest that co�?existence of" exact="influenza" post="virus with other viruses in clinical specimens should not"/>
  <result pre="cell substrates that can eliminate the contaminating viruses and amplify" exact="influenza" post="viruses. Roth et al reported that MDCK 33016PF cells"/>
  <result pre="(identical to MDCK�?S cells) could remove adventitious viruses and propagate" exact="influenza" post="viruses.13 In the present study, we analyzed the property"/>
  <result pre="the same results as both cell lines could propagate all" exact="influenza" post="viruses and remove all adventitious agents from multiple infection"/>
  <result pre="of vaccine seed viruses. Regarding LLC�?MK2D, the isolation rate of" exact="influenza" post="viruses was 9.1% (n = 22), whereas that in"/>
  <result pre="to MDCK�?S and MDCK�?A considering its low ability to multiply" exact="influenza" post="viruses and to eliminate the contaminating viruses. One of"/>
  <result pre="broader patterns of multiple infections for the selective isolation of" exact="influenza" post="viruses. Another limitation is the lack of follow�?up studies"/>
  <result pre="reported that adherent MDCK cells (MDCK�?A) showed no growth of" exact="mumps" post="viruses, measles viruses, rubella viruses, herpes simplex viruses, cytomegaloviruses,"/>
  <result pre="adherent MDCK cells (MDCK�?A) showed no growth of mumps viruses," exact="measles" post="viruses, rubella viruses, herpes simplex viruses, cytomegaloviruses, and parechoviruses18;"/>
  <result pre="cells (MDCK�?A) showed no growth of mumps viruses, measles viruses," exact="rubella" post="viruses, herpes simplex viruses, cytomegaloviruses, and parechoviruses18; hence, there"/>
  <result pre="showed no growth of mumps viruses, measles viruses, rubella viruses," exact="herpes simplex" post="viruses, cytomegaloviruses, and parechoviruses18; hence, there seems to be"/>
  <result pre="virus emerges that can replicate well in MDCK cells with" exact="influenza" post="viruses, it might be difficult to prepare seed viruses"/>
  <result pre="because plasmids with no virus are starting materials to produce" exact="influenza" post="viruses. A(H3N2) viruses particularly have serious problems such as"/>
  <result pre="alterations during egg adaptation.19, 20 Recently, the US�?FDA approved an" exact="influenza" post="vaccine with cell�?derived seed virus.21 It is thus expected"/>
  <result pre="preparation of vaccine seed viruses without adventitious agents. However, new" exact="influenza" post="viruses might appear that have lower abilities to replicate"/>
  <result pre="and use them together to facilitate the amplification of variable" exact="influenza" post="viruses. The use of MDCK�?S, MDCK�?A, and other cell"/>
  <result pre="GargS, et al. Annual estimates of the burden of seasonal" exact="influenza" post="in the United States: a tool for strengthening influenza"/>
  <result pre="seasonal influenza in the United States: a tool for strengthening" exact="influenza" post="surveillance and preparedness. Influenza Other Respir Viruses. 2018;12:132�?137.29446233 3MolinariN�?A,"/>
  <result pre="3MolinariN�?A, Ortega�?SanchezIR, MessonnierML, et al. The annual impact of seasonal" exact="influenza" post="in the US: measuring disease burden and costs. Vaccine."/>
  <result pre="4SchildGC, OxfordJS, de JongJC, WebsterRG. Evidence for host�?cell selection of" exact="influenza" post="virus antigenic variants. Nature. 1983;303:706�?709.6190093 5RobertsonJS, NicolsonC, BootmanJS, MajorD,"/>
  <result pre="MajorD, RobertsonEW, WoodJM. Sequence analysis of the haemagglutinin (HA) of" exact="influenza" post="A (H1N1) viruses present in clinical material and comparison"/>
  <result pre="Influence of host cell�?mediated variation on the international surveillance of" exact="influenza" post="A (H3N2) viruses. Virology. 1993;196:130�?137.8356790 7RochaEP, XuX, HallHE, AllenJR,"/>
  <result pre="1993;196:130�?137.8356790 7RochaEP, XuX, HallHE, AllenJR, RegneryHL, CoxNJ. Comparison of 10" exact="influenza" post="A (H1N1 and H3N2) haemagglutinin sequences obtained directly from"/>
  <result pre="Virol. 1993;74:2513�?2518.8245870 8SaitoT, NakayaY, SuzukiT, et al. Antigenic alteration of" exact="influenza" post="B virus associated with loss of a glycosylation site"/>
  <result pre="Virol. 2004;74:336�?343.15332284 9ChenZ, AspelundA, JinH. Stabilizing the glycosylation pattern of" exact="influenza" post="B hemagglutinin following adaptation to growth in eggs. Vaccine."/>
  <result pre="10TobitaK, SugiuraA, EnomoteC, FuruyamaM. Plaque assay and primary isolation of" exact="influenza" post="A viruses in an established line of canine kidney"/>
  <result pre="characteristics of qualified cell lines for isolation and propagation of" exact="influenza" post="viruses for vaccine manufacturing. Vaccine. 2014;32:6583�?6590.24975811 12DoroshenkoA, HalperinSA. Trivalent"/>
  <result pre="vaccine manufacturing. Vaccine. 2014;32:6583�?6590.24975811 12DoroshenkoA, HalperinSA. Trivalent MDCK cell culture�?derived" exact="influenza" post="vaccine Optaflu (Novartis Vaccines). Expert Rev Vaccines. 2009;8:679�?688.19485748 13RothB,"/>
  <result pre="Rev Vaccines. 2009;8:679�?688.19485748 13RothB, MohrH, EndersM, GartenW, GregersenJP. Isolation of" exact="influenza" post="viruses in MDCK 33016PF cells and clearance of contaminating"/>
  <result pre="J Exp Med. 1962;115:903�?918.14449901 15EvansAS, OlsonB. Rapid diagnostic methods for" exact="influenza" post="virus in clinical specimens: a comparative study. Yale J"/>
  <result pre="LLC�?MK2 cell lines with enzyme immunoassay for the isolation of" exact="influenza" post="and parainfluenza viruses from clinical specimens. J Virol Methods."/>
  <result pre="IlyushinaN, WebsterRG, WebbyRJ. Molecular changes associated with adaptation of human" exact="influenza" post="A virus in embryonated chicken eggs. Virology. 2006;350:137�?145.16545416 20StevensJ,"/>
  <result pre="Virology. 2006;350:137�?145.16545416 20StevensJ, ChenL�?M, CarneyPJ, et al. Receptor specificity of" exact="influenza" post="A H3N2 viruses isolated in mammalian cells and embryonated"/>
  <result pre="J Virol. 2010;84:8287�?8299.20519409 21BarrIG, DonisRO, KatzJM, et al. Cell culture�?derived" exact="influenza" post="vaccines in the severe 2017–2018 epidemic season: a step"/>
  <result pre="in the severe 2017–2018 epidemic season: a step towards improved" exact="influenza" post="vaccine effectiveness. NPJ Vaccines. 2018;3:44.30323955"/>
 </snippets>
</snippetsTree>
